+ All Categories
Home > Documents > Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf ·...

Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf ·...

Date post: 05-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
4
Wilson’s disease in an elderly patient MAZIAR BADII, HENRY WONG MD,URS PSTEINBRECHER MD,HUGH JFREEMAN MD I N 1911, WILSON DESCRIBED A “PURE syndrome of the corpus striatum” de- veloping “always in young people” with a “constant presence of profound cir- rhosis of the liver” (1). Since that time, Wilson’s disease has been widely re- garded as a disease whose initial mani- festations almost always occur in indi- viduals younger than 40 years of age. Young children typically present with liver disease, whereas in teenagers and young adults, neurological manifesta- tions predominate (2). However, there are a few very rare case reports of Wil- son’s disease with apparent onset in late adulthood (3-7). We report a male patient with Fan- coni’s syndrome who was first diag- nosed with Wilson’s disease at age 65 years after he presented for diagnostic assessment of chronic liver disease. The clinical diagnosis was based on the presence of bilateral Kayser-Fleischer rings, a decreased serum ceruloplasmin level, markedly elevated urine copper excretion and a liver biopsy staining histochemically positive for copper. CASE PRESENTATION A 65-year-old man with renal fail- ure and Fanconi’s syndrome was seen in January 1992 for investigation of chronic liver disease. In 1967, he de- veloped a seizure disorder after sustain- ing a head injury with loss of consciousness; he was subsequently treated with phenytoin 200 mg daily. Fanconi’s syndrome was diagnosed in 1984 (at age 57) with a pattern of gener- alized amino- aciduria, hyperphospha- turia and osteomalacia. Liver disease was first identified at age 61 years when the patient presented with ascites. A liver biopsy was performed. This yielded a fragmented specimen that was reported to reveal fibrosis and ‘pi- gmentation’ but no specific diagnosis was established. Because of his chronic liver disease and worsening ascites, the patient was referred for further evaluation. He complained of easy bruising, leg edema, BRIEF COMMUNICATION – HEPATOLOGY MBADII,HWONG, UP STEINBRECHER, HJ FREEMAN. Wilson’s disease in an elderly patient. Can J Gastroenterol 1995;9(2):78-80. A 65-year-old man with Fanconi’s syndrome was investigated for the cause of chronic liver disease. Wilson’s disease was diagnosed based on the detection of bilateral Kayser- Fleischer rings, a low serum ceruloplasmin level, increased urine copper excre- tion and positive histochemical stains of his liver for copper. This case is unusual because of the patient’s elderly age at the time of diagnosis and the absence of neurological changes due to Wilson’s disease in spite of advanced hepatic disease and the presence of Kayser-Fleischer rings. Even in the elderly patient, Wilson’s disease should be considered a possible cause of chronic liver disease. Key Words: Cirrhosis, Copper metabolism, Fanconi’s syndrome, Hepatolenticular degeneration, Kayser-Fleischer rings, Wilson’s disease Maladie de Wilson chez un sujet âgé RÉSUMÉ : Un homme de 65 ans atteint du syndrome de Fanconi a subi des épreuves afin d’identifier la cause de cette maladie hépatique chronique. La mala- die de Wilson a été diagnostiquée sur la base de la présence d’anneaux de Kayser- Fleischer bilatéraux, d’un taux de céruloplasmine sérique faible et de l’excrétion cuprique urinaire accrue, ainsi que de la coloration histochimique positive de son foie pour y dépister la présence de cuivre. Ce cas est inhabituel à cause de l’âge avancé du patient au moment du diagnostic et de l’absence de signes neurolo- giques attribuables à la maladie de Wilson, malgré une maladie hépatique avan- cée et la présence d’anneaux de Kayser-Fleischer. Même chez le patient âgé, la maladie de Wilson est à envisager comme cause possible de maladie hépatique chronique. Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, British Columbia Correspondence and reprints: Dr Hugh Freeman, ACU F-137, Gastroenterology, Vancouver Hospital (UBC Site), 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1W5. Telephone (604) 822-7216 Received for publication May 31, 1994. Accepted August 15, 1994 78 CAN JGASTROENTEROL VOL 9NO 2MARCH/APRIL 1995
Transcript
Page 1: Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf · Wilson’s disease in an elderly patient MAZIAR BADII, HENRY WONG MD,URS PSTEINBRECHER

Wilson’s disease in an elderlypatient

MAZIAR BADII, HENRY WONG MD, URS P STEINBRECHER MD, HUGH J FREEMAN MD

IN 1911, WILSON DESCRIBED A “PURE

syndrome of the corpus striatum” de-veloping “always in young people” witha “constant presence of profound cir-rhosis of the liver” (1). Since that time,Wilson’s disease has been widely re-

garded as a disease whose initial mani-festations almost always occur in indi-viduals younger than 40 years of age.Young children typically present withliver disease, whereas in teenagers andyoung adults, neurological manifesta-

tions predominate (2). However, thereare a few very rare case reports of Wil-son’s disease with apparent onset inlate adulthood (3-7).

We report a male patient with Fan-coni’s syndrome who was first diag-nosed with Wilson’s disease at age 65years after he presented for diagnosticassessment of chronic liver disease. Theclinical diagnosis was based on thepresence of bilateral Kayser-Fleischerrings, a decreased serum ceruloplasminlevel, markedly elevated urine copperexcretion and a liver biopsy staininghistochemically positive for copper.

CASE PRESENTATIONA 65-year-old man with renal fail-

ure and Fanconi’s syndrome was seen inJanuary 1992 for investigation ofchronic liver disease. In 1967, he de-veloped a seizure disorder after sustain-ing a head injury with loss ofconsciousness; he was subsequentlytreated with phenytoin 200 mg daily.Fanconi’s syndrome was diagnosed in1984 (at age 57) with a pattern of gener-alized amino- aciduria, hyperphospha-turia and osteomalacia. Liver diseasewas first identified at age 61 years whenthe patient presented with ascites. Aliver biopsy was performed. Thisyielded a fragmented specimen thatwas reported to reveal fibrosis and ‘pi-gmentation’ but no specific diagnosiswas established.

Because of his chronic liver diseaseand worsening ascites, the patient wasreferred for further evaluation. Hecomplained of easy bruising, leg edema,

BRIEF COMMUNICATION – HEPATOLOGY

M BADII, H WONG, UP STEINBRECHER, HJ FREEMAN. Wilson’s disease in anelderly patient. Can J Gastroenterol 1995;9(2):78-80. A 65-year-old manwith Fanconi’s syndrome was investigated for the cause of chronic liver disease.Wilson’s disease was diagnosed based on the detection of bilateral Kayser-Fleischer rings, a low serum ceruloplasmin level, increased urine copper excre-tion and positive histochemical stains of his liver for copper. This case is unusualbecause of the patient’s elderly age at the time of diagnosis and the absence ofneurological changes due to Wilson’s disease in spite of advanced hepatic diseaseand the presence of Kayser-Fleischer rings. Even in the elderly patient, Wilson’sdisease should be considered a possible cause of chronic liver disease.

Key Words: Cirrhosis, Copper metabolism, Fanconi’s syndrome, Hepatolenticulardegeneration, Kayser-Fleischer rings, Wilson’s disease

Maladie de Wilson chez un sujet âgé

RÉSUMÉ : Un homme de 65 ans atteint du syndrome de Fanconi a subi desépreuves afin d’identifier la cause de cette maladie hépatique chronique. La mala-die de Wilson a été diagnostiquée sur la base de la présence d’anneaux de Kayser-Fleischer bilatéraux, d’un taux de céruloplasmine sérique faible et de l’excrétioncuprique urinaire accrue, ainsi que de la coloration histochimique positive de sonfoie pour y dépister la présence de cuivre. Ce cas est inhabituel à cause de l’âgeavancé du patient au moment du diagnostic et de l’absence de signes neurolo-giques attribuables à la maladie de Wilson, malgré une maladie hépatique avan-cée et la présence d’anneaux de Kayser-Fleischer. Même chez le patient âgé, lamaladie de Wilson est à envisager comme cause possible de maladie hépatiquechronique.

Department of Medicine (Gastroenterology), University of British Columbia, Vancouver,British Columbia

Correspondence and reprints: Dr Hugh Freeman, ACU F-137, Gastroenterology,Vancouver Hospital (UBC Site), 2211 Wesbrook Mall, Vancouver, British ColumbiaV6T 1W5. Telephone (604) 822-7216

Received for publication May 31, 1994. Accepted August 15, 1994

78 CAN J GASTROENTEROL VOL 9 NO 2 MARCH/APRIL 1995

Page 2: Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf · Wilson’s disease in an elderly patient MAZIAR BADII, HENRY WONG MD,URS PSTEINBRECHER

weight gain of 14 kg, anorexia and in-ability to concentrate. There was nohistory of risk factors for parenterallytransmitted viral hepatitis or alcoholabuse. There was no family history ofknown liver disease or neuropsychiat-ric disorder.

His original liver biopsies were re-viewed and the paraffin-embeddedliver tissue blocks were reprocessed forhistochemical stains; sections testedpositive with orcein and rubeanic acidstains for copper.

Physical examination revealed ahealthy appearing man with no clinicalevidence of jaundice. Bilateral Kay-ser-Fleischer rings were visible tothe naked eye and later confirmed onslit lamp biomicroscopy (Figure 1).Other less frequently reported ocularchanges, ie, sunflower cataracts or anintraocular foreign body containingcopper (chalcosis), were not seen. Neu-rological examination was normal ex-cept for slight right facial drooping. Hisabdomen was markedly distended withascites. Peripheral stigmata of chronicliver disease were evident includingspider nevi, gynecomastia, palmer ery-thema, multiple bruises and Dupuy-tren’s contractures. Edema was presentbilaterally to the midabdomen.

Laboratory investigations revealed(normal range in parentheses): hemo-globin 123 g/L (140 to 180); whiteblood cell count 3.1x109/L (4 to11x109); platelets 90x109/L (140 to350x109); serum creatinine 198 �mol/L(80 to 120); blood urea nitrogen 7.5mM (2.5 to 6.8); alkaline phosphatase95 U/L (30 to 110); aspartate amino-transferase 28 U/L (5 to 47); total bili-rubin 17 �mol/L (2 to 23); interna-tional normalized ratio 1.5 (0.9 to 1.2);and serum albumin 36 g/L (35 to 50).Serum copper was 16.0 �mol/L (nor-mal 11.0 to 22.0) and serum ceruloplas-min was 75 mg/L (normal 150 to 600).Antinuclear and antimitochondrial an-tibodies were negative. Iron studies andalpha-1-antitrypsin were normal. Se-rological studies for hepatitis A, Band C were negative. Urine copperwas 4.8 �mol/24 h (normal 0.5 to 0.9).

An abdominal ultrasound showedmassive ascites and a small, nodularliver. Bile ducts were not dilated and

no gallstones were seen. A paracentesisrevealed a transudate with negative cy-tology. Upper endoscopy revealed eso-phageal, but no gastric, varices.Computed tomography and magneticresonance imaging of the brain showedgeneralized atrophy but no changes inthe basal ganglia.

The patient was treated with peni-cillamine 500 mg bid, and this in-creased his urinary copper excretion to18.1 �mol/24 h.

DISCUSSIONDifferent mechanisms have been

implicated in the pathogenesis of Wil-son’s disease. The liver acts as a depotfor copper. As the disease progresses,due to an inherited defect not yet com-pletely understood, copper bindingsites in the liver become saturated.This factor, along with direct hepato-cellular damage, results in release ofcopper into the blood, which then pro-ceeds to deposit in the cornea and basalganglia (7). The reversal of abnormalcopper metabolism in patients after or-thotopic liver transplantation supportsthe critical role played in the patho-genesis of Wilson’s disease by the liver.

Recent studies have provided dataon the identification of the gene re-sponsible for Wilson’s disease, whichhas been identified on chromosome 13.The gene product appears to be a

copper-binding P-type ATPase proteinand is apparently homologous to theMenkes disease gene (8). Mutationanalysis has so far uncovered a numberof disease-specific mutations, includingtransversions and frame shift muta-tions, affecting the Wilson’s diseaseprotein (8).

Many texts of general internalmedicine assert that Wilson’s disease isgenerally a disorder of patients youngerthan 40 years of age. It is believed thatthe hepatic form generally occurs inchildren while the neurological form isgenerally, but not exclusively, seen inolder patients.

It has been stated that Kayser-Fleischer rings and the neurologicalmanifestations of the disease are in-variably present together (2). The pres-ent case illustrates that these dicta arenot necessarily true even though mod-ern methods of imaging detection forcentral nervous system involvement inWilson’s disease were used in our pa-tient, including computed tomographyand magnetic resonance.

Despite his age of 65, there is littlequestion that this patient – withchronic liver disease and Fanconi’s syn-drome – had Wilson’s disease. His diag-nosis was based on a high urine copperexcretion measurement, the presenceof bilateral Kayser-Fleischer rings, areduced serum ceruloplasmin level and

Figure 1) Kayser-Fleischer ring on peripheral region of cornea in patient with Wilson’s disease.Other ophthalmological features found in Wilson’s disease, such as sunflower cataracts, were absent

CAN J GASTROENTEROL VOL 9 NO 2 MARCH/APRIL 1995 79

Wilson’s disease in the elderly

Page 3: Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf · Wilson’s disease in an elderly patient MAZIAR BADII, HENRY WONG MD,URS PSTEINBRECHER
Page 4: Wilson’s disease in an elderly patientdownloads.hindawi.com/journals/cjgh/1995/352692.pdf · Wilson’s disease in an elderly patient MAZIAR BADII, HENRY WONG MD,URS PSTEINBRECHER

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com


Recommended